Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Core Scientific
CORZ
$6.36B
| $2.21M | ﹤0.01% |
+238,000
| New | +$1.22M |
|
|
CGAU
1827
Centerra Gold
CGAU
$4.15B
| $2.2M | ﹤0.01% |
327,800
+73,600
| +29% | +$483K |
|
|
PHLT
1828
DELISTED
Performant Healthcare Inc
PHLT
| $2.19M | ﹤0.01% |
755,663
-8,500
| -1% | -$24.4K |
|
1829
Transcat
TRNS
$888M
| $2.19M | ﹤0.01% |
18,300
-10,700
| -37% | -$1.26M |
|
1830
Corebridge Financial
CRBG
$15.3B
| $2.19M | ﹤0.01% |
75,200
-646,100
| -90% | -$18.6M |
|
1831
Hippo Holdings
HIPO
$869M
| $2.18M | ﹤0.01% |
126,904
-24,216
| -16% | -$459K |
|
|
DADA
1832
DELISTED
Dada Nexus
DADA
| $2.17M | ﹤0.01% |
1,721,900
+380,100
| +28% | +$684K |
|
1833
SEACOR Marine Holdings
SMHI
$262M
| $2.17M | ﹤0.01% |
160,800
-11,300
| -7% | -$147K |
|
|
MTLS
1834
Materialise
MTLS
$397M
| $2.17M | ﹤0.01% |
432,655
-97,484
| -18% | -$502K |
|
1835
Compugen
CGEN
$228M
| $2.17M | ﹤0.01% |
1,288,900
-8,100
| -0.6% | -$16.9K |
|
|
YALA
1836
Yalla Group
YALA
$823M
| $2.16M | ﹤0.01% |
475,700
| – | – |
|
1837
Green Brick Partners
GRBK
$3.04B
| $2.16M | ﹤0.01% |
37,809
+16,700
| +79% | +$933K |
|
1838
Chegg
CHGG
$89.3M
| $2.16M | ﹤0.01% |
682,200
+210,191
| +45% | +$1.04M |
|
1839
Republic Bancorp
RBCAA
$1.92B
| $2.16M | ﹤0.01% |
40,200
+2,100
| +6% | +$107K |
|
1840
Greif Class B
GEF.B
$4.22B
| $2.15M | ﹤0.01% |
34,400
-1,800
| -5% | -$116K |
|
|
GRP.U
1841
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.15M | ﹤0.01% |
43,300
-8,700
| -17% | -$446K |
|
1842
Oppenheimer Holdings
OPY
$1.23B
| $2.14M | ﹤0.01% |
44,769
-6,439
| -13% | -$275K |
|
1843
State Street SPDR S&P Retail ETF
XRT
$643M
| $2.14M | ﹤0.01% |
28,600
-20,400
| -42% | -$1.52M |
|
1844
Rocket Pharmaceuticals
RCKT
$367M
| $2.14M | ﹤0.01% |
+99,574
| New | +$2.29M |
|
1845
Fossil Group
FOSL
$330M
| $2.14M | ﹤0.01% |
1,485,585
-16,700
| -1% | -$19K |
|
1846
Abeona Therapeutics
ABEO
$361M
| $2.13M | ﹤0.01% |
503,293
+429,456
| +582% | +$2.19M |
|
1847
Ginkgo Bioworks
DNA
$488M
| $2.13M | ﹤0.01% |
+159,173
| New | +$4.75M |
|
1848
Airgain
AIRG
$67.7M
| $2.13M | ﹤0.01% |
352,336
+2,800
| +0.8% | +$15.3K |
|
1849
STRATTEC Security
STRT
$338M
| $2.13M | ﹤0.01% |
85,106
+8,500
| +11% | +$210K |
|
1850
Genius Sports
GENI
$2.2B
| $2.13M | ﹤0.01% |
390,000
+33,522
| +9% | +$179K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.